Yup, and I was told he never made that statement.
But it is a moot point. MAde or not made, the statement relates to number of tests, not tests sold.
But we've done this to death already right?
Printable View
Yup, and I was told he never made that statement.
But it is a moot point. MAde or not made, the statement relates to number of tests, not tests sold.
But we've done this to death already right?
Yes Balance me old mate
Like it or not PEB head honchos have anchored all thinking about the future around 'several tens of thousands of tests during 2014' and achieving $100m of revenues in 5 years (start/end date keeps moving)
So progress ( and commentary) will always come back back to those anchors.
I still believe that 'successful commercialisation' in PEB terms does not mean making a profit ....aim to get it used and a source of funds for the next project. They are scientists after all.
The payday for punters, if there is one, will be when the science is bought by somebody else.
Been around too long to fall for that BS from a company - it is significant and material enough to seek a retraction or issue a statement from the company.
Especially when it led to a price spike and the Chairman sold into that spiked price.
Question of trust, integrity and transparency.
And I AM writing as a shareholder.
Let it go Balance.
We have no idea how many tests they may have put through under the User programmes etc
Let's hope you are right there and the directors also have that in mind.
I bought into 42Below on the same basis when they cracked 100,000 cases - the directors were very clear that when at that success level, someone would buy them.
A takeover happened within months.
Well... I think it's kinda stupid (that word is a bit harsh but can't think of a more relevant one) to say that he's confident they'll process several tens of thousands of tests during 2014, just like it was "stupid" again not quite the right word, that they caused a blunder yesterday due to the announcement. Nevertheless, he was CLEARLY (as some have mentioned but I think some fail to realise) referring to the quantity going through their labs rather than dollars getting invoiced. Now.. A large/huge/majority of these will be from the LUGs, so not paid for. But VERY important, why? As Mentioned in the report by Edison's - a big initial factor to determine/drive the success of cxbladder is to convert these non-paid tests into paid tests. In the report we will be able to at least estimate relatively accurately how many tests were sold. I don't know that we will find out how many tests were processed... but we should, as he made the comment about a number. I don't suppose anyone knows whether or not we will know the number of tests processed at any stage? I don't think it's something they have to report on, and if not they shouldn't be commenting on. But I like to think he got slapped for that anyway, and that there was some slapping yesterday too. As the share price rises, and the company gains profile etc... all of a sudden you go from a $10m cap startup coy to a hundreds of million dollar company - you gotta style things a little differently. You know what I'm saying?
Makes you wonder with yesterdays debacle.
Both announcements were listed as price sensitive.
The first, regarding CxBladder, was a stuff up and PEB said afterwards that February it WILL be patented. The CxColorectal announcement, the second one, was the correct one. So, if both were in the bag...
If it is price sensitive you are supposed to IMMEDIATELY release the information to the market.
If they didn't screw up yesterday how long were they going to wait to tell us then? How long had they been sitting on both announcements for? What else is sitting there that we don't know about?
I'm sorry, but people that can't see this as de ja vu of last terrible report and ANOTHER try at a cover up are pretty blind.
At the very least the NZXR/FMA should be asking some very thorny questions about was known and what wasn't at what time.
Sorry guys, but faith in this company, the little that was left, has been totally blown out of the water for me.
GL to all holders. You're going to need it.
Oh come now BFG , you have a pack of Winnie Blues riding on this. Disclose and be gone.
Well perhaps amongst all the noise the obvious merits may be being overlooked,
Two patents covering 38 European countries bodes pretty well as far as working toward establishing another very significant major market goes, and a market that is notably twice the size of the US too.
It’s not easy to get a patent in Europe, hardest place in the World, and they have achieved two such patents within just a few months, and for their two most prospective products no less.
I feel some anguish for whoever made the mistake at Pacific Edge yesterday but it in no way distracts one bit from the damned fine effort the good folk at Pacific Edge are doing.
Especially our fellow Kiwi’s in Dunedin, leading the world in this tech.
Well done PEB, superb effort.
Why the SP reflect valuation(a bit elusive wouldnt you say?--Are you talking about the $1.70 valuation or .85 valuation?)instead of sales----Ask Mr Market --He will tell you
Couldnt agree more with your 1st paragraph though(doesnt apply to me --Im on the sidelines at this point(I decided to be content just being in the black for now)
last paragraph--if you want to gamble--who am I to disagree?